You're starting to make the same mistake as the pumpers, but in the other direction. $ENDV either has the goods or they don't. If they don't release positive trial results before the money runs out this year, then they're probably toast and 1 cent/share might look good. But any kind of good news in the next month or so, that excites the investing public and pulls in favorable financing, and things are going to get mighty interesting. Why are your price targets any more likely than the new 52 week highs people were predicting?